The CABROLVI brand, founded in 2015 (United Kingdom), from 1722 sister brands and 17477 competing brands. CABROLVI is owned by GSK PLC, listed on the stock exchange of Francfort The International Securities Identification Number (ISIN) of GSK PLC is GB00BN7SWP63. CABROLVI belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
GSK PLC
(CABROLVI)
over 5 years*
EUR 16.30